IDCases · 2026
Early plasma cell-free DNA diagnosis of fatal Acanthamoeba granulomatous amebic encephalitis in a liver transplant recipient.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hill-Mak Julie, Danobeitia J Sebastian, Perez Alejandro
Аннотация
BACKGROUND: Acanthamoeba granulomatous amebic encephalitis (GAE) is a rare, highly lethal opportunistic infection in immunocompromised hosts. Diagnosis is difficult because clinical and radiographic findings are nonspecific and conventional cerebrospinal fluid (CSF) studies may be nondiagnostic.
CASE: We report a 68-year-old woman who developed fever, seizures, and progressive encephalopathy 13 days after orthotopic liver transplantation. Brain MRI demonstrated multifocal supratentorial and infratentorial enhancing lesions with vasogenic edema and peripheral diffusion restriction. Initial CSF bacterial, viral, and fungal studies were negative. Plasma microbial cell-free DNA (mcfDNA) sequencing identified Acanthamoeba species 5 days after admission, prompting expedited Centers for Disease Control and Prevention (CDC) consultation and initiation of multidrug anti-amoebic therapy. CDC CSF real-time PCR subsequently confirmed Acanthamoeba infection. Despite antimicrobial escalation and reduction of immunosuppression, cerebral abscesses, progressive edema and uncal herniation developed and the patient died.
CONCLUSION: Plasma mcfDNA provided rapid, noninvasive organism identification of an unsuspected free-living amoebic CNS infection and directed confirmatory testing and therapy. It should be considered an adjunct diagnostic tool rather than a replacement for CSF or tissue testing. Results require clinical correlation and confirmation with site-specific testing when feasible.
CASE: We report a 68-year-old woman who developed fever, seizures, and progressive encephalopathy 13 days after orthotopic liver transplantation. Brain MRI demonstrated multifocal supratentorial and infratentorial enhancing lesions with vasogenic edema and peripheral diffusion restriction. Initial CSF bacterial, viral, and fungal studies were negative. Plasma microbial cell-free DNA (mcfDNA) sequencing identified Acanthamoeba species 5 days after admission, prompting expedited Centers for Disease Control and Prevention (CDC) consultation and initiation of multidrug anti-amoebic therapy. CDC CSF real-time PCR subsequently confirmed Acanthamoeba infection. Despite antimicrobial escalation and reduction of immunosuppression, cerebral abscesses, progressive edema and uncal herniation developed and the patient died.
CONCLUSION: Plasma mcfDNA provided rapid, noninvasive organism identification of an unsuspected free-living amoebic CNS infection and directed confirmatory testing and therapy. It should be considered an adjunct diagnostic tool rather than a replacement for CSF or tissue testing. Results require clinical correlation and confirmation with site-specific testing when feasible.